As for irreplaceable medicines, or essential medicines for which manufacturers 'profit margins are low--i.e. those in 20 major categories such as meds for rare diseases, insulin, coagulants, and so on--the BNHI promises that the prices will not be changed, in order to ensure a reliable supply of these life-saving drugs.
至於那些不可取代，或是藥廠利潤很低，又有其必要的藥品，如罕見疾病用藥、胰島素、凝血因子等 20 大類，健保局保證不調降藥價，以保障這類救命藥物穩定供應。